FOCL (Edap TMS) ROE % Adjusted to Book Value: -17.80% (As of Mar. 2026)


FOCL Edap TMS SA FOCL
53 GF Score
Price $5.08
GF Value $4.52
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Edap TMS ROE % Adjusted to Book Value?

Edap TMS FOCL +1.91% 53 ROE % Adjusted to Book Value is -17.80% as of Mar. 2026. GuruFocus rates FOCL with a GF Score™ of 53/100 and a GF Value™ of $4.52 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Edap TMS's ROE % for the quarter that ended in Mar. 2026 was -246.20%. Edap TMS's PB Ratio for the quarter that ended in Mar. 2026 was 13.83. Edap TMS's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -17.80%.


Edap TMS ROE % Adjusted to Book Value Related Terms


Edap TMS ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Edap TMS's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Edap TMS ROE % Adjusted to Book Value Chart

Edap TMS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.50 -0.92 -10.77 -20.03 -14.88

Edap TMS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -37.89 -39.76 -24.98 -60.36 -17.80

FOCL vs ACH, YI, COSM: ROE % Adjusted to Book Value Comparison

For the Medical Distribution subindustry, Edap TMS's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Edap TMS ROE % Adjusted to Book Value vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Edap TMS's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Edap TMS's ROE % Adjusted to Book Value falls into.


FOCL
53GF Score
Edap TMS SA FOCL
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Edap TMS ROE % Adjusted to Book Value Calculation

Edap TMS's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-94.50% / 6.35
=-14.88%

Edap TMS's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-246.20% / 13.83
=-17.80%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -17.80% mean?
Edap TMS (FOCL) has a ROE % Adjusted to Book Value of -17.80% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Edap TMS and its competitors.
Is Edap TMS's ROE % Adjusted to Book Value too high?
Edap TMS's current ROE % Adjusted to Book Value is -17.80%. Overall, Edap TMS has a GF Score™ of 53/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Edap TMS's ROE % Adjusted to Book Value compare to ACH and YI?
Edap TMS's ROE % Adjusted to Book Value of -17.80% can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Distribution company?
A good ROE % Adjusted to Book Value depends on the Medical Distribution industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Edap TMS and its competitors. Edap TMS's current ROE % Adjusted to Book Value is -17.80%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Edap TMS stock overvalued right now?
Based on GuruFocus' analysis, Edap TMS (FOCL) is currently considered Modestly Overvalued. The stock's GF Value™ is $4.52, compared to a current price of $5.08 — trading 12.3% above its estimated fair value. The current ROE % Adjusted to Book Value is -17.80%. Edap TMS's overall GF Score™ is 53/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Edap TMS (FOCL), the current ROE % Adjusted to Book Value is -17.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Edap TMS (FOCL) Overvalued in 2026?

Based on GuruFocus' analysis, Edap TMS stock appears to be overvalued. The current stock price of $5.08 is trading 12.3% above its estimated GF Value™ of $4.52. GuruFocus considers Edap TMS to be Modestly Overvalued.

Key valuation signals for FOCL:

  • ROE % Adjusted to Book Value: -17.80%
  • GF Value™: $4.52 vs. price of $5.08 (12.3% above fair value)
  • GF Score™: 53/100 with 7 warning signs

No single metric tells the full story. See the FOCL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Edap TMS Business Description

Other Exchanges EDA:Germany
Address Parc d\'Activites La Poudrette-Lamartine, 4/6, rue du Dauphine, Vaulx-en-Velin, FRA, 69120
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.
53GF Score

Get the complete analysis for FOCL

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.08
Price
$4.52
GF Value